Research Progress in the Role of Tim3/galectin-9 in Hematological Malignancy--Review / 中国实验血液学杂志
Journal of Experimental Hematology
;
(6): 1360-1364, 2021.
Artículo
en Chino
| WPRIM
| ID: wpr-888567
ABSTRACT
The incidence of hematological malignant tumor is increasing year by year, and seriously affecting the human health. In addition to the traditional radiation and chemotherapy, immunotherapy has achieved a certain effect in the treatment of blood tumor, but it is limited by exhaustion of CD8
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Linfocitos T CD8-positivos
/
Neoplasias Hematológicas
/
Galectinas
/
Receptor 2 Celular del Virus de la Hepatitis A
/
Inmunoterapia
Límite:
Humanos
Idioma:
Chino
Revista:
Journal of Experimental Hematology
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS